Nano-X Imaging Ltd.

NASDAQ:NNOX

Medical - Devices

Healthcare
$0.73 -1.45%

-$0.03 today

Market cap
$50.94M
Beta
1.17
P/E (TTM)
-1.5
EPS (TTM)
-$1.12
52W Low $1.59High $5.69

Volume 0.52M

Average 1.46M

NNOX Interest Expense

Cost of servicing the company's debt during the period.

Nano-X Imaging Ltd.NASDAQ: NNOX

Interest Expense · Q4 FY2025 · quarter ended Dec 2025

Interest expense remains negative

Q4 FY2025 interest expense was $0, compared with $0 a year earlier. Trailing-twelve-month interest expense was $149K.

Context

  • Interest expense amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Interest expense increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly interest expense holds near $0 or moves back toward the trailing-twelve-month quarterly average of $37.25K.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterDec 2025
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
LTMDec 2025
$149K— YoY
Interest Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Interest Expense history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
—

Interest Expense vs competitors

How NNOX compares with its peers on the latest reported figures

  • NNOX's LTM Dec 2025 interest expense of $149K is the 7th highest of the 11 companies compared; the peer median is $491K.
  • Interest expense amounts to 1.1% of revenue for NNOX, versus a peer median of 6.3%.
NNOX Competitors Peer median
Interest Expense for NNOX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
HCATHealth Catalyst, Inc.LTM Mar 2026$21.68M -4.0%+31.3%7.2%
OMOutset Medical, Inc.LTM Mar 2026$7.02M -67.3%+57.6%6.0%
TLSITriSalus Life Sciences, Inc.LTM Mar 2026$5.77M +34.3%+1669.9%12.9%
SNWVSANUWAVE Health, Inc.LTM Mar 2026$4.94M -58.6%-23.8%11.1%
HSDTSolana CompanyLTM Mar 2026$629K +6888.9%-8.7%6.6%
CATXPerspective Therapeutics, Inc.LTM Mar 2026$353K +140.1%—57.1%
NNOXNano-X Imaging Ltd.LTM Dec 2025$149K ——1.1%
PROFProfound Medical Corp.LTM Mar 2026$0 -100.0%—0.0%
INGNInogen, Inc.LTM Mar 2026$0 ——0.0%
MXCTMaxCyte, Inc.LTM Mar 2026$0 ——0.0%
QTRXQuanterix CorporationLTM Mar 2026$0 ——0.0%
Peer median (excluding NNOX) $491K-4.0%+31.3%6.3%

Competitors are the stored peer set for NNOX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.3M8.58M9.91M11.28M13.02M
Cost of Revenue2.82M15.46M16.5M21.89M25.81M
Gross Profit(1.51M)(6.88M)(6.59M)(10.61M)(12.79M)
Gross Margin-116.0%-80.2%-66.6%-94.0%-98.2%
Research & Development17.12M26.51M26.05M20.18M19.24M
Selling, General & Admin41.74M45.63M28.39M25.75M27.1M
Operating Expenses60.05M72.33M56M46.14M47.91M
Depreciation & Amortization2.29M11.51M11.81M11.73M11.7M
EBITDA(59.27M)(75.7M)(47.69M)(45.01M)(49M)
EBITDA Margin-4544.9%-882.4%-481.5%-398.9%-376.3%
Operating Income(61.56M)(109.71M)(62.59M)(56.75M)(60.7M)
Operating Margin-4720.7%-1279.0%-631.9%-502.9%-466.2%
Interest Income0789K1.65M2.87M1.42M
Interest Expense288K0000
Other Income / Expenses(288K)(14.67M)1.47M2.87M(16.11M)
Income Before Tax(61.85M)(108.92M)(61.12M)(53.87M)(76.81M)
Pre-Tax Margin-4742.8%-1269.8%-617.0%-477.5%-589.9%
Income Tax Expense(48K)(3.68M)(339K)(358K)(1.79M)
Net Income(61.8M)(105.24M)(60.78M)(53.52M)(75.02M)
Net Margin-4739.1%-1226.9%-613.6%-474.3%-576.1%
EPS (Basic)(1.28)(2.01)(1.08)(0.91)(1.16)
EPS (Diluted)(1.28)(2.01)(1.08)(0.91)(1.16)
Weighted Avg Shares48.22M52.24M56.37M58.62M64.79M
Weighted Avg Shares (Diluted)48.22M52.24M56.37M58.62M64.79M

Nano-X Imaging Ltd.

NASDAQ:NNOX

Intrinsic Alpha fair value

Locked

Current Price

$0.73

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.